Avoro Capital Advisors LLC
Q3 2022 13F-HR Holdings
Net value change ($000)
+352,282
(7.0%)
New positions
2
Sold out positions
3
Turnover %
1.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| APLS | 248,156 | 56.0% |
| SRPT | 96,851 | 38.1% |
| ASND | 82,807 | 39.2% |
| BCRX | 45,260 | 65.8% |
| IVERIC bio, Inc. | 37,352 | 54.5% |
| BMRN | 29,259 | 10.8% |
| XENE | 27,832 | 18.7% |
| ALNY | 22,821 | 11.5% |
| KYMR | 22,415 | 90.4% |
| AMLX | 18,298 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| UTHR | -87,100 | -12.4% |
| Horizon Therapeutics Public Ltd Co | -81,614 | -20.5% |
| XBI | -66,843 | -100.0% |
| KURA | -39,832 | -45.3% |
| ARGX | -32,689 | -6.8% |
| IOVA | -15,377 | -15.1% |
| Seagen Inc. | -14,646 | -5.4% |
| RARE | -13,687 | -30.6% |
| MDGL | -10,115 | -9.2% |
| FOLD | -8,040 | -2.8% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|